Literature DB >> 21200035

Protection from colorectal cancer after colonoscopy: a population-based, case-control study.

Hermann Brenner1, Jenny Chang-Claude, Christoph M Seiler, Alexander Rickert, Michael Hoffmeister.   

Abstract

BACKGROUND: Colonoscopy with detection and removal of adenomas is considered a powerful tool to reduce colorectal cancer (CRC) incidence. However, the degree of protection achievable in a population setting with high-quality colonoscopy resources remains to be quantified.
OBJECTIVE: To assess the association between previous colonoscopy and risk for CRC.
DESIGN: Population-based case-control study.
SETTING: Rhine-Neckar region of Germany. PATIENTS: A total of 1688 case patients with colorectal cancer and 1932 control participants aged 50 years or older. MEASUREMENTS: A detailed lifetime history of CRC risk factors and preventive factors, including history and results of previous colonoscopies, and of medical data obtained by self-reports and medical records. Odds ratios of CRC associated with colonoscopy in the preceding 10 years were estimated, after adjustment for sex, age, education level, participation in a general health screening examination, family history of CRC, smoking status, body mass index, and use of nonsteroidal anti-inflammatory drugs or hormone replacement therapy.
RESULTS: Overall, colonoscopy in the preceding 10 years was associated with 77% lower risk for CRC. Adjusted odds ratios for any CRC, right-sided CRC, and left-sided CRC were 0.23 (95% CI, 0.19 to 0.27), 0.44 (CI, 0.35 to 0.55), and 0.16 (CI, 0.12 to 0.20), respectively. Strong risk reduction was observed for all cancer stages and all ages, except for right-sided cancer in persons aged 50 to 59 years. Risk reduction increased over the years in both the right and the left colon. LIMITATION: The study was observational, with potential for residual confounding and selection bias.
CONCLUSION: Colonoscopy with polypectomy can be associated with strongly reduced risk for CRC in the population setting. Aside from strong risk reduction with respect to left-sided CRC, risk reduction of more than 50% was also seen for right-sided colon cancer. PRIMARY FUNDING SOURCE: German Research Council and German Federal Ministry of Education and Research.

Entities:  

Mesh:

Year:  2011        PMID: 21200035     DOI: 10.7326/0003-4819-154-1-201101040-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  280 in total

1.  Treatment of alcoholic methadone-maintenance patients with disulfiram.

Authors:  A Pugliese; M Martinez; A Maselli; D H Zalick
Journal:  J Stud Alcohol       Date:  1975-11

2.  Removal of infused water predominantly during insertion (water exchange) is consistently associated with an increase in adenoma detection rate - review of data in randomized controlled trials (RCTs) of water-related methods.

Authors:  Fw Leung; Jo Harker; Jw Leung; Rm Siao-Salera; Sk Mann; Fc Ramirez; S Friedland; A Amato; F Radaelli; S Paggi; V Terruzzi; Yh Hsieh
Journal:  J Interv Gastroenterol       Date:  2011-07-01

3.  A head-to-head comparison of the water vs. air method in patients undergoing screening colonoscopy.

Authors:  Francisco C Ramirez; Felix W Leung
Journal:  J Interv Gastroenterol       Date:  2011-07-01

4.  Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty.

Authors:  Nancy N Baxter; Joan L Warren; Michael J Barrett; Therese A Stukel; V Paul Doria-Rose
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

5.  The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer.

Authors:  M F Kaminski; M Bretthauer; A G Zauber; E J Kuipers; H-O Adami; M van Ballegooijen; J Regula; M van Leerdam; T Stefansson; L Påhlman; E Dekker; M A Hernán; K Garborg; G Hoff
Journal:  Endoscopy       Date:  2012-06-21       Impact factor: 10.093

6.  Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis.

Authors:  Amanda I Phipps; Michael N Passarelli; Andrew T Chan; Tabitha A Harrison; Jihyoun Jeon; Carolyn M Hutter; Sonja I Berndt; Hermann Brenner; Bette J Caan; Peter T Campbell; Jenny Chang-Claude; Stephen J Chanock; Jeremy P Cheadle; Keith R Curtis; David Duggan; David Fisher; Charles S Fuchs; Manish Gala; Edward L Giovannucci; Richard B Hayes; Michael Hoffmeister; Li Hsu; Eric J Jacobs; Lina Jansen; Richard Kaplan; Elisabeth J Kap; Timothy S Maughan; John D Potter; Robert E Schoen; Daniela Seminara; Martha L Slattery; Hannah West; Emily White; Ulrike Peters; Polly A Newcomb
Journal:  Carcinogenesis       Date:  2015-11-19       Impact factor: 4.944

7.  eRapa restores a normal life span in a FAP mouse model.

Authors:  Paul Hasty; Carolina B Livi; Sherry G Dodds; Diane Jones; Randy Strong; Martin Javors; Kathleen E Fischer; Lauren Sloane; Kruthi Murthy; Gene Hubbard; Lishi Sun; Vincent Hurez; Tyler J Curiel; Zelton Dave Sharp
Journal:  Cancer Prev Res (Phila)       Date:  2013-11-26

Review 8.  Advances in endoscopy for colorectal polyp detection and classification.

Authors:  Vijeta Pamudurthy; Nayna Lodhia; Vani J A Konda
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-12-18

Review 9.  Multi-target stool DNA test: a new high bar for noninvasive screening.

Authors:  David A Ahlquist
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

10.  Quality indicators for colorectal cancer screening for colonoscopy.

Authors:  Philip S Schoenfeld; Jonathan Cohen
Journal:  Tech Gastrointest Endosc       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.